Home ProductsMedical Intermediate

White BBCA Aztreonam Medical Intermediate Powder Cas 78110-38-0

Certification
China ANHUI BBCA PHARMACEUTICAL CO.,LTD certification
China ANHUI BBCA PHARMACEUTICAL CO.,LTD certification
Customer Reviews
Dear Sunny, Thank you so much for your company for quick shipment of the goods,we have caught up with the market. Best Rgeards, Erci Mohammad

—— Eric Mohammad

Dear Sunny, The quality of Paracetamol is very good,our customer is very satisfied.Thank you so much! Best Regards, Jean Green

—— Jean Green

I'm Online Chat Now

White BBCA Aztreonam Medical Intermediate Powder Cas 78110-38-0

White BBCA Aztreonam  Medical Intermediate Powder Cas 78110-38-0
White BBCA Aztreonam  Medical Intermediate Powder Cas 78110-38-0 White BBCA Aztreonam  Medical Intermediate Powder Cas 78110-38-0

Large Image :  White BBCA Aztreonam Medical Intermediate Powder Cas 78110-38-0

Product Details:
Place of Origin: China
Brand Name: BBCA
Certification: GMP
Model Number: BBCA18011210
Payment & Shipping Terms:
Minimum Order Quantity: 5000 KGS
Price: Negotiated
Packaging Details: 10kg/tin
Delivery Time: 10 DAYS AFTER PAYMENT
Payment Terms: L/C, T/T, , MoneyGram, L/C, T/T, , MoneyGram
Supply Ability: 500 MTS PER YEAR

White BBCA Aztreonam Medical Intermediate Powder Cas 78110-38-0

Description
CAS No.: 78110-38-0 Place Of Origin: China (Mainland)
Brand Name: BBCA Other Names: Made In China Aztreonam Cas 78110-38-0
Appearancelline Powder: White Crystalline Powder MF: C13H17N5O8S2
EINECS No.: 278-839-9 Grade Standard: Medicine Grade
Type: Antibiotic And Antimicrobial Agents
High Light:

chloramine t

,

medical raw materials

White BBCA Aztreonam Medical Intermediate Powder Cas 78110-38-0

 

Product Description

Aztreonam (trade names Azactam injection, Cayston inhalation) is a monobactam antibiotic used primarily to treat infections caused by gram-negative bacteria. It is a synthetic drug based on a simpler monobactam isolated from Chromobacterium violaceum. It is resistant to some beta-lactamases, but is inactivated by extended-spectrum beta-lactamases.
It was approved by the U.S. Food and Drug Administration (FDA) in 1986.

 

Specification

Items Specification Analysis Result
Appearance White, odorless crystalline powder Conform
Identification The retention times of the major peaks in the chromatogram of the assay preparation correspond to those of the Standard preparation obtained in the assay Conform
Color of Solution

Not more than yellow or

greenish- yellow Reference Solution II

Conform
Clarity of solution Not more than Turbidity Standard I Conform
PH 4.5~7.5 5.2

Related

Impurities

Single impurities Not more than1.0% 0.34%
Total impurities Not more than3.0% 1.25%
Water Content Not more than 2.0% 0.3%
Residue of ignition Not more than 0.1% Conform
Heavy Metals Not more than 30ppm Conform
Bacterial Endotoxins Not more than 0.17EU/mg (Aztreonam) Conform
Sterility Test Sterile (without germs in 14 days) Conform
Particulate matter

≥10µm, no more than 2500/g

≥25µm, no more than 250/g

1084

67

Assay

Contain C13H17N5O8S2 90.0% ~105.0%

(Calculated on anhydrous substance without L-Arginine )

99.5%
L-Arginine content 42%~45%

43.4%

 

Contact Details
ANHUI BBCA PHARMACEUTICAL CO.,LTD

Contact Person: Cora Hu

Tel: 86-15255150259

Send your inquiry directly to us (0 / 3000)